QIAGEN N.V. (QGEN) Stock Fundamental Analysis
USA - NYSE:QGEN - NL0015002CX3 - Common Stock
45.895 USD
+0.48 (+1.05%)
Overall QGEN gets a fundamental rating of 6 out of 10. We evaluated QGEN against 55 industry peers in the Life Sciences Tools & Services industry. QGEN has an excellent profitability rating, but there are some minor concerns on its financial health. QGEN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
QGEN had a positive operating cash flow in the past year.
In the past 5 years QGEN has always been profitable.
QGEN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QGEN has a Return On Assets of 6.41%. This is amongst the best in the industry. QGEN outperforms 81.82% of its industry peers.
The Return On Equity of QGEN (10.65%) is better than 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 8.66%, QGEN belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QGEN is significantly below the industry average of 15.96%.
The 3 year average ROIC (7.25%) for QGEN is below the current ROIC(8.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROIC | 8.66% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
The Profit Margin of QGEN (18.30%) is better than 90.91% of its industry peers.
QGEN's Profit Margin has declined in the last couple of years.
The Operating Margin of QGEN (26.86%) is better than 94.55% of its industry peers.
In the last couple of years the Operating Margin of QGEN has grown nicely.
Looking at the Gross Margin, with a value of 64.18%, QGEN belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QGEN is creating some value.
QGEN has less shares outstanding than it did 1 year ago.
QGEN has less shares outstanding than it did 5 years ago.
QGEN has a better debt/assets ratio than last year.
2.2 Solvency
QGEN has an Altman-Z score of 3.96. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
QGEN's Altman-Z score of 3.96 is fine compared to the rest of the industry. QGEN outperforms 78.18% of its industry peers.
The Debt to FCF ratio of QGEN is 2.91, which is a good value as it means it would take QGEN, 2.91 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.91, QGEN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
QGEN has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
QGEN's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. QGEN outperforms 52.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Altman-Z | 3.96 |
ROIC/WACC1.13
WACC7.63%
2.3 Liquidity
QGEN has a Current Ratio of 1.61. This is a normal value and indicates that QGEN is financially healthy and should not expect problems in meeting its short term obligations.
QGEN's Current ratio of 1.61 is on the low side compared to the rest of the industry. QGEN is outperformed by 69.09% of its industry peers.
A Quick Ratio of 1.35 indicates that QGEN should not have too much problems paying its short term obligations.
QGEN has a Quick ratio of 1.35. This is in the lower half of the industry: QGEN underperforms 69.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
QGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.20%, which is quite good.
QGEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
The Revenue has been growing slightly by 5.15% in the past year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
3.2 Future
QGEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.02% yearly.
QGEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
QGEN is valuated rather expensively with a Price/Earnings ratio of 19.53.
Compared to the rest of the industry, the Price/Earnings ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 85.45% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, QGEN is valued a bit cheaper.
QGEN is valuated rather expensively with a Price/Forward Earnings ratio of 17.68.
Based on the Price/Forward Earnings ratio, QGEN is valued cheaper than 85.45% of the companies in the same industry.
QGEN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.53 | ||
| Fwd PE | 17.68 |
4.2 Price Multiples
QGEN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QGEN is cheaper than 87.27% of the companies in the same industry.
QGEN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. QGEN is cheaper than 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.06 | ||
| EV/EBITDA | 13.73 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
QGEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.32
EPS Next 2Y8.09%
EPS Next 3Y8.68%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.54%, which is pretty low.
Compared to an average industry Dividend Yield of 1.09, QGEN pays a better dividend. On top of this QGEN pays more dividend than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.09%
EPS Next 3Y8.68%
NYSE:QGEN (9/18/2025, 10:35:01 AM)
45.895
+0.48 (+1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.24%
Inst Owner Change-22.15%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap9.95B
Analysts75
Price Target52.82 (15.09%)
Short Float %3.15%
Short Ratio4.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)2.48%
PT rev (3m)4.48%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)0.96%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)2%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.53 | ||
| Fwd PE | 17.68 | ||
| P/S | 4.88 | ||
| P/FCF | 20.06 | ||
| P/OCF | 14.74 | ||
| P/B | 2.84 | ||
| P/tB | 15.57 | ||
| EV/EBITDA | 13.73 |
EPS(TTM)2.35
EY5.12%
EPS(NY)2.6
Fwd EY5.66%
FCF(TTM)2.29
FCFY4.98%
OCF(TTM)3.11
OCFY6.78%
SpS9.41
BVpS16.17
TBVpS2.95
PEG (NY)2.48
PEG (5Y)2.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROCE | 11.67% | ||
| ROIC | 8.66% | ||
| ROICexc | 10.87% | ||
| ROICexgc | 46.44% | ||
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% | ||
| FCFM | 24.31% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 94.78% | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.61% | ||
| Profit Quality | 132.83% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.96 |
F-Score8
WACC7.63%
ROIC/WACC1.13
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.62%
EBIT Next 5Y14.77%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%